Chemical Structure : BCL6 inhibitor 79-6
CAS No.: 301356-95-6
Catalog No.: PC-60926Not For Human Use, Lab Use Only.
BCL6 inhibitor 79-6 (Compound 79-6) is the first-generation, specific BCL6 BTB domain inhibitor with IC50 of 200 uM, Kd of 129 uM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $88 | In stock | |
10 mg | $128 | In stock | |
25 mg | $218 | In stock | |
50 mg | $358 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BCL6 inhibitor 79-6 (Compound 79-6, CID5721353) is the first-generation, specific BCL6 BTB domain inhibitor with IC50 of 200 uM, Kd of 129 uM.
BCL6 inhibitor 79-6 binds to a pocket in the lateral groove of the BCL6 BTB domain, specifically inhibits BCL6 but not other BTB-ZF proteins.
BCL6 inhibitor 79-6 disrupts BCL6/corepressor complexes and reactivates BCL6 target genes in vitro and in vivo, selectively kills BCL6-dependent DLBCL cells.
BCL6 inhibitor 79-6 suppresses human DLBCL xenografts in mice with favorable pharmacokinetics.
M.Wt | 457.269 | |
Formula | C15H9BrN2O6S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(Z)-2-(5-(5-bromo-2-oxoindolin-3-ylidene)-4-oxo-2-thioxothiazolidin-3-yl)succinic acid |
1. Cerchietti LC, et al. Cancer Cell. 2010 Apr 13;17(4):400-11.
2. Cardenas MG, et al. J Clin Invest. 2016 Sep 1;126(9):3351-62.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright